{
  "main_header": {
    "sid": 1156931,
    "name": "Ligand Pharmaceuticals, Inc.",
    "stock_name": "Ligand Pharmaceuticals, Inc.",
    "full_name": "Ligand Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/ligand-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "188.50",
    "chg": -6.6,
    "chgp": "-3.38%",
    "dir": -1,
    "prev_price": "195.10",
    "mcapval": "3,250.29",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US53220K5048",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "388.69 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ligand-pharmaceuticals-inc-1156931-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Ligand Pharmaceuticals Experiences Valuation Adjustment Amidst Competitive Market Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ligand-pharmaceuticals-changes-valuation-grade-from-risky-to-expensive-amid-losses-3686225",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LigandPharmaceu_valuationdot_3686225.png",
        "date": "2025-11-10 15:46:25",
        "description": "Ligand Pharmaceuticals, Inc. has adjusted its valuation amid operational challenges, reporting a price-to-book value of 2.57 and an EV to EBITDA of 88.07. Despite difficulties reflected in negative ROCE and ROE, the company has shown strong stock performance, significantly outperforming the S&P 500 year-to-date."
      },
      {
        "title": "Ligand Pharmaceuticals Hits Day High with 9.91% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ligand-pharmaceuticals-hits-day-high-with-991-surge-in-stock-price-3680224",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LigandPharmaceu_priceRelatedfactors_3680224.png",
        "date": "2025-11-07 16:32:57",
        "description": "Ligand Pharmaceuticals, Inc. saw a notable increase in stock performance on November 6, 2025, reaching an intraday high. The company has outperformed the S&P 500 over various periods, but it faces challenges such as negative net profit and low return on capital, raising concerns about its long-term viability."
      },
      {
        "title": "Ligand Pharmaceuticals Hits New 52-Week High of $211.91",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ligand-pharmaceuticals-hits-new-52-week-high-of-21191-3680140",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LigandPharmaceu_priceRelatedfactors_3680140.png",
        "date": "2025-11-07 15:58:40",
        "description": "Ligand Pharmaceuticals, Inc. has achieved a new 52-week high, highlighting its strong performance in the Pharmaceuticals and Biotechnology sector. The company has seen significant stock price growth over the past year, outpacing the S&P 500, despite being loss-making and having no dividend yield."
      },
      {
        "title": "Ligand Pharmaceuticals Hits New 52-Week High of $189.60",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ligand-pharmaceuticals-hits-new-52-week-high-of-18960-3649212",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/LigandPharmaceu_priceRelatedfactors_3649212.png",
        "date": "2025-10-27 16:43:26",
        "description": "Ligand Pharmaceuticals, Inc. achieved a new 52-week high of USD 189.60 on October 24, 2025, reflecting a significant increase in its stock price over the past year. With a market capitalization of USD 3,250 million, the company remains unprofitable and does not offer dividends, typical for growth-focused biotech firms."
      },
      {
        "title": "Ligand Pharmaceuticals Hits New 52-Week High of $186.40",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ligand-pharmaceuticals-hits-new-52-week-high-of-18640-3607954",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/LigandPharmaceu_priceRelatedfactors_3607954.png",
        "date": "2025-10-09 19:58:50",
        "description": "Ligand Pharmaceuticals, Inc. achieved a new 52-week high of USD 186.40 on October 8, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen significant stock price growth over the past year, despite being loss-making, with notable financial metrics indicating its market positioning."
      },
      {
        "title": "Ligand Pharmaceuticals Hits New 52-Week High of $184.26",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ligand-pharmaceuticals-hits-new-52-week-high-of-18426-3601540",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/LigandPharmaceu_priceRelatedfactors_3601540.png",
        "date": "2025-10-07 21:36:54",
        "description": "Ligand Pharmaceuticals, Inc. achieved a new 52-week high of USD 184.26 on October 6, 2025, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen significant stock price growth over the past year, despite being loss-making and having a negative return on equity."
      },
      {
        "title": "Ligand Pharmaceuticals Hits New 52-Week High of $183.81",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ligand-pharmaceuticals-hits-new-52-week-high-of-18381-3595554",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/LigandPharmaceu_priceRelatedfactors_3595554.png",
        "date": "2025-10-06 17:22:52",
        "description": "Ligand Pharmaceuticals, Inc. achieved a new 52-week high of USD 183.81 on October 3, 2025, reflecting a significant increase in stock performance over the past year. Despite this milestone, the company remains unprofitable, with a negative return on equity and no dividend yield."
      },
      {
        "title": "Ligand Pharmaceuticals Hits New 52-Week High of $181.62",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ligand-pharmaceuticals-hits-new-52-week-high-of-18162-3588304",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/LigandPharmaceu_priceRelatedfactors_3588304.png",
        "date": "2025-10-02 22:26:41",
        "description": "Ligand Pharmaceuticals, Inc. achieved a new 52-week high of USD 181.62 on October 1, 2025, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen significant growth over the past year, with a notable increase in stock price, despite being loss-making and not offering dividends."
      },
      {
        "title": "Ligand Pharmaceuticals Hits New 52-Week High at $177.77",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ligand-pharmaceuticals-hits-new-52-week-high-at-17777-3585992",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/LigandPharmaceu_priceRelatedfactors_3585992.png",
        "date": "2025-10-01 16:31:14",
        "description": "Ligand Pharmaceuticals, Inc. achieved a new 52-week high of USD 177.77 on September 30, 2025, reflecting strong performance in the pharmaceuticals sector. The company has seen a significant stock price increase over the past year, despite being loss-making, and maintains a focus on growth and reinvestment."
      }
    ],
    "total": 19,
    "sid": "1156931",
    "stock_news_url": "https://www.marketsmojo.com/news/ligand-pharmaceuticals-inc-1156931"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Ligand Pharmaceuticals Experiences Valuation Adjustment Amidst Competitive Market Landscape

2025-11-10 15:46:25

Ligand Pharmaceuticals, Inc. has adjusted its valuation amid operational challenges, reporting a price-to-book value of 2.57 and an EV to EBITDA of 88.07. Despite difficulties reflected in negative ROCE and ROE, the company has shown strong stock performance, significantly outperforming the S&P 500 year-to-date.

Read More

Ligand Pharmaceuticals Hits Day High with 9.91% Surge in Stock Price

2025-11-07 16:32:57

Ligand Pharmaceuticals, Inc. saw a notable increase in stock performance on November 6, 2025, reaching an intraday high. The company has outperformed the S&P 500 over various periods, but it faces challenges such as negative net profit and low return on capital, raising concerns about its long-term viability.

Read More

Ligand Pharmaceuticals Hits New 52-Week High of $211.91

2025-11-07 15:58:40

Ligand Pharmaceuticals, Inc. has achieved a new 52-week high, highlighting its strong performance in the Pharmaceuticals and Biotechnology sector. The company has seen significant stock price growth over the past year, outpacing the S&P 500, despite being loss-making and having no dividend yield.

Read More

Ligand Pharmaceuticals Hits New 52-Week High of $189.60

2025-10-27 16:43:26

Ligand Pharmaceuticals, Inc. achieved a new 52-week high of USD 189.60 on October 24, 2025, reflecting a significant increase in its stock price over the past year. With a market capitalization of USD 3,250 million, the company remains unprofitable and does not offer dividends, typical for growth-focused biotech firms.

Read More

Ligand Pharmaceuticals Hits New 52-Week High of $186.40

2025-10-09 19:58:50

Ligand Pharmaceuticals, Inc. achieved a new 52-week high of USD 186.40 on October 8, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen significant stock price growth over the past year, despite being loss-making, with notable financial metrics indicating its market positioning.

Read More

Ligand Pharmaceuticals Hits New 52-Week High of $184.26

2025-10-07 21:36:54

Ligand Pharmaceuticals, Inc. achieved a new 52-week high of USD 184.26 on October 6, 2025, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen significant stock price growth over the past year, despite being loss-making and having a negative return on equity.

Read More

Ligand Pharmaceuticals Hits New 52-Week High of $183.81

2025-10-06 17:22:52

Ligand Pharmaceuticals, Inc. achieved a new 52-week high of USD 183.81 on October 3, 2025, reflecting a significant increase in stock performance over the past year. Despite this milestone, the company remains unprofitable, with a negative return on equity and no dividend yield.

Read More

Ligand Pharmaceuticals Hits New 52-Week High of $181.62

2025-10-02 22:26:41

Ligand Pharmaceuticals, Inc. achieved a new 52-week high of USD 181.62 on October 1, 2025, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen significant growth over the past year, with a notable increase in stock price, despite being loss-making and not offering dividends.

Read More

Ligand Pharmaceuticals Hits New 52-Week High at $177.77

2025-10-01 16:31:14

Ligand Pharmaceuticals, Inc. achieved a new 52-week high of USD 177.77 on September 30, 2025, reflecting strong performance in the pharmaceuticals sector. The company has seen a significant stock price increase over the past year, despite being loss-making, and maintains a focus on growth and reinvestment.

Read More

View All News